Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the immune system mistakenly attacks the lining of the joints, causing pain, swelling, and progressive damage to cartilage and bone. As of 2019, roughly 18 million people worldwide were living with the condition, and women are two to three times more likely to develop it than men.
What Happens Inside the Joints
Every joint is wrapped in a thin membrane called the synovium, which normally produces a small amount of fluid that keeps the joint lubricated. In RA, immune cells, particularly certain types of T cells, macrophages, and B cells, flood into this membrane and trigger inflammation. The synovium thickens dramatically, new blood vessels grow into it, and it begins producing chemicals that eat away at nearby cartilage and bone.
A specific group of immune cells drives much of the destruction. Inflammatory macrophages interact with cells in the joint lining called fibroblasts, transforming them into an aggressive type that churns out cartilage- and bone-destroying molecules along with more inflammatory signals. This creates a self-reinforcing cycle: inflammation breeds more inflammation, and the joint steadily deteriorates if the process isn’t interrupted by treatment. Over months or years, this can lead to visible joint deformity, loss of function, and chronic pain.
Early Symptoms and How RA Feels
The hallmark of RA is joint pain and swelling that typically affects both sides of the body in a symmetric pattern. It usually starts in the small joints of the hands, fingers, and wrists before moving to larger joints like the knees, shoulders, and ankles. One of the most distinctive features is prolonged morning stiffness, usually lasting longer than one hour. That time frame is a key difference from osteoarthritis, where stiffness tends to improve within 30 minutes or less.
Fatigue is another early and often underestimated symptom. Many people describe a deep, whole-body tiredness that doesn’t improve with rest. Low-grade fevers and a general feeling of being unwell can also appear before joint symptoms become obvious. Because these early signs overlap with many other conditions, RA can be difficult to recognize at first.
How RA Differs From Osteoarthritis
Osteoarthritis is a wear-and-tear condition that breaks down joint cartilage over time, usually affecting weight-bearing joints and the hands. RA is fundamentally different because it’s driven by the immune system, not by mechanical stress. This means RA can strike at any age (though it most commonly appears between 30 and 60), affects joints symmetrically, and causes systemic symptoms like fatigue and inflammation throughout the body. Osteoarthritis tends to worsen with activity, while RA stiffness is worst after periods of rest and gradually improves with movement.
Effects Beyond the Joints
RA is not just a joint disease. The same inflammatory process that attacks the synovium can affect organs throughout the body. People with RA have a higher risk of hardened and blocked arteries, raising the chance of heart attack and stroke. Inflammation can also affect the sac surrounding the heart.
The lungs are another common target. Chronic inflammation of lung tissue can cause scarring that leads to progressively worsening shortness of breath. Firm lumps called rheumatoid nodules can form under the skin, most often near the elbows, but they sometimes develop in the lungs or heart as well.
Many people with RA also develop a condition called secondary Sjögren’s syndrome, which reduces moisture production in the eyes and mouth, leading to persistent dryness, eye irritation, and difficulty swallowing.
How RA Is Diagnosed
There’s no single test that confirms RA. Doctors use a combination of physical examination, blood tests, and imaging to make a diagnosis. The starting point is the presence of at least one visibly swollen joint that can’t be better explained by another condition.
Two blood tests are central to the workup. Rheumatoid factor (RF) is positive in many people with RA, with a sensitivity around 91%, but it can also show up in people with other conditions, making its specificity lower at about 74%. A newer test, anti-CCP antibody, is nearly as sensitive (88%) but considerably more specific (90%), meaning a positive result is more likely to point to RA specifically. Doctors often order both tests together, which improves overall diagnostic accuracy to roughly 90%.
Blood markers of inflammation, such as CRP and ESR, are also checked. These don’t diagnose RA on their own, but elevated levels add supporting evidence. The formal classification system scores four areas: the number and type of joints involved (small joints score higher), blood test results, inflammation markers, and whether symptoms have lasted six weeks or longer. A score of 6 out of 10 or higher confirms a diagnosis of definite RA.
Treatment Goals and Approach
The overarching goal of RA treatment is to reach sustained remission or, when that isn’t possible, the lowest level of disease activity. This “treat-to-target” strategy means your doctor will regularly measure your disease activity and adjust medications if the current plan isn’t working well enough. Early, aggressive treatment gives the best chance of preventing joint damage.
The first line of treatment is a category of drugs called disease-modifying antirheumatic drugs (DMARDs), which slow or stop the immune process that causes joint destruction. Methotrexate is typically the starting point and remains the backbone of RA therapy for most people. If methotrexate alone isn’t enough, doctors add biologic therapies, which are injected or infused medications that block specific inflammatory molecules. These include drugs that target tumor necrosis factor (a key driver of inflammation), as well as therapies that interrupt other immune signaling pathways.
A newer class, JAK inhibitors, works by blocking signaling inside immune cells and is taken as a pill rather than an injection. In clinical trials, 30 to 70% of patients using DMARDs, either alone or in combination, achieve partial responses. With biologic therapies targeting TNF, as many as 70% of patients see significant improvement, though full remission remains less common.
Diet and Lifestyle Factors
While no diet can replace medication, certain eating patterns have shown measurable effects on disease activity. A Mediterranean-style diet, rich in fish, olive oil, vegetables, and whole grains, has demonstrated benefits in intervention studies. Omega-3 fatty acids from fish or supplements appear to reduce joint tenderness and inflammation markers. Some evidence also supports probiotics, vitamin D supplementation, and antioxidant-rich foods, though the research on each of these is still limited in scope.
Regular physical activity, particularly low-impact exercise like swimming, cycling, and walking, helps maintain joint mobility, reduce stiffness, and preserve muscle strength around affected joints. Many people find that consistent movement actually reduces pain over time, even though it can feel counterintuitive when joints are sore.